Learn More
OBJECTIVE To determine whether lung function alters asthma severity based on symptom history in asthmatic adolescents. DESIGN Data on asthma symptoms and lung function were collected from(More)
Targeting CD3 antigens on human T lymphocytes with monoclonal antibodies has been shown to reduce the rate of decline of C-peptides in recent-onset type 1 diabetes mellitus patients. However,(More)
AIMS Phase III DEFEND-2 investigated whether otelixizumab (3.1 mg over 8 days) preserved C-peptide secretion in patients with new-onset Type 1 diabetes, focusing on adolescents (12-17 years). (More)
  • 1